Structured Summary
Abstract
A proteolytic enzyme obtained from the venom of fer-de-lance (BOTHROPS ATROX). It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Hemocoagulase is a mixture containing batroxobin and factor X activator. EC 3.4.21.-.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
6 entry terms
- Defibrol
- Defibrase
- Hemocoagulase
- Reptilase
- Reptilase-DEF
- Reptilase DEF
MeSH Record
Aspects Covered
29 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2000(1975); for PLASMOCOAGULASE use BATROXOBIN (NM) 1979-1999
MeSH Record
Previous Indexing
- Peptide Hydrolases (1969-1974)
- Snakes (1969-1974)
- Venoms (1969-1974)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Batroxobin. Medical Subject Headings (MeSH). 2026. Unique ID D012103. http://id.nlm.nih.gov/mesh/2026/D012103
- Batroxobin. In: Wikipedia. https://en.wikipedia.org/wiki/Batroxobin
- Batroxobin. In: Wikidata. https://www.wikidata.org/wiki/Q993771